Your browser doesn't support javascript.
loading
Pharmacological and neuroethological study of the acute and chronic effects of lamotrigine in the genetic audiogenic seizure hamster (GASH:Sal).
Barrera-Bailón, B; Oliveira, J A C; López, D E; Muñoz, L J; Garcia-Cairasco, N; Sancho, C.
Afiliación
  • Barrera-Bailón B; Institute of Neurosciences of Castilla and León/IBSAL, University of Salamanca, Salamanca, Spain.
  • Oliveira JAC; Physiology Department, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto, Brazil.
  • López DE; Institute of Neurosciences of Castilla and León/IBSAL, University of Salamanca, Salamanca, Spain; Department of Cell Biology and Pathology, School of Medicine, University of Salamanca, Salamanca, Spain.
  • Muñoz LJ; Animal Research Service, University of Salamanca, Salamanca, Spain.
  • Garcia-Cairasco N; Physiology Department, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto, Brazil. Electronic address: ngcairas@fmrp.usp.br.
  • Sancho C; Institute of Neurosciences of Castilla and León/IBSAL, University of Salamanca, Salamanca, Spain; Department of Physiology and Pharmacology, School of Medicine, University of Salamanca, Salamanca, Spain. Electronic address: sanchoc@usal.es.
Epilepsy Behav ; 71(Pt B): 207-217, 2017 06.
Article en En | MEDLINE | ID: mdl-26876275
ABSTRACT
The present study aimed to investigate the behavioral and anticonvulsant effects of lamotrigine (LTG) on the genetic audiogenic seizure hamster (GASHSal), an animal model of audiogenic seizure that is in the validation process. To evaluate the efficiency of acute and chronic treatments with LTG, GASHSals were treated with LTG either acutely via intraperitoneal injection (5-20mg/kg) or chronically via oral administration (20-25mg/kg/day). Their behavior was assessed via neuroethological analysis, and the anticonvulsant effect of LTG was evaluated based on the appearance and the severity of seizures. The results showed that acute administration of LTG exerts an anticonvulsant effect at the lowest dose tested (5mg/kg) and that chronic oral LTG treatment exerts an anticonvulsant effect at a dose of 20-25mg/kg/day. Furthermore, LTG treatment induced a low rate of secondary adverse effects. This article is part of a Special Issue entitled "Genetic and Reflex Epilepsies, Audiogenic Seizures and Strains From Experimental Models to the Clinic".
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Convulsiones / Triazinas / Epilepsia Refleja / Modelos Animales de Enfermedad / Anticonvulsivantes Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Epilepsy Behav Asunto de la revista: CIENCIAS DO COMPORTAMENTO / NEUROLOGIA Año: 2017 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Convulsiones / Triazinas / Epilepsia Refleja / Modelos Animales de Enfermedad / Anticonvulsivantes Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Epilepsy Behav Asunto de la revista: CIENCIAS DO COMPORTAMENTO / NEUROLOGIA Año: 2017 Tipo del documento: Article País de afiliación: España